RxDoctor Payments Data

Kristine Kerestan Garbig

Optometrist · Wilder, KYNPI 1043277577

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,758 of the $50,810 with a category attached, or 66.4%. Alcon accounts for 97.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $21,156 and has fallen 98.9% since, to $229 in 2025. Among optometrist clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,810in general payments, 2019–2025

Across 162 payments — averaging $313.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$49K
  • Shire North American Group Inc$333
  • Optos, Inc.$290
  • Tarsus Pharmaceuticals, Inc.$214
  • Coopervision Inc.$148
  • Rxsight Inc$103
  • plus $333 from 7 others

What the payments were for

  • Consulting fees$33,75866%
  • Travel & lodging$12,14324%
  • Food & beverage$4,6009%
  • Gifts$190%
  • Entertainment$2901%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,810 in reported general payments places this provider in the 95th percentile of 712 optometrist providers in Kentucky.

See all optometrist providers in Kentucky

Medicare billing

Part B allowed, 2024
$7,823
Medicare patients
52
Services billed
170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost20$69

Paid to pharmacies, not to this prescriber.

Other optometrist in Wilder

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →